Christine Pellizzari - Jun 13, 2024 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Director
Signature
/s/ Nicholas Maestas, Attorney-in-Fact for Christine Pellizzari
Stock symbol
TPST
Transactions as of
Jun 13, 2024
Transactions value $
$0
Form type
4
Date filed
6/14/2024, 06:05 PM
Previous filing
Jun 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Stock Option (right to buy) Award $0 +16 K $0.00 16 K Jun 13, 2024 Common Stock 16 K $3.03 Direct F1

Explanation of Responses:

Id Content
F1 The shares underlying the option will vest in full on the earlier of (i) June 13, 2025, or (ii) the day of the Issuer's 2025 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date.